Patents by Inventor Jeffery Lee Wood

Jeffery Lee Wood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound, corresponding compositions, preparation and/or treatment methods
    Patent number: 8158645
    Abstract: Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: April 17, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Philip C. Dell'Orco, Ann Marie Diederich, Qiaogong Su, Jeffery Lee Wood
  • NOVEL COMPOUND, CORRESPONDING COMPOSITIONS, PREPARATION AND/OR TREATMENT METHODS
    Publication number: 20100210677
    Abstract: Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases.
    Type: Application
    Filed: April 30, 2010
    Publication date: August 19, 2010
    Inventors: Philip C. DELL'ORCO, Ann Marie Diederich, Qiaogong Su, Jeffery Lee Wood
  • Crystalline topotecan hydrochloride product and process for making the same
    Patent number: 7754733
    Abstract: Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]4-ethyl-4,9-dihydroxy-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinoline-3,14(4H, 12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer related diseases.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: July 13, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Philip C. Dell'orco, Ann Marie Diederich, Qiaogong Su, Jeffery Lee Wood